Company intelligence / Profile preview

Delivra Health Brands

Ownership: Private
Development stage: Other

Overview

Delivra Health Brands has developed a proprietary transdermal delivery technology that enables deeper penetration of active ingredients into skin and muscle tissue. Clinical studies have shown their LivRelief™ cream delivers water-soluble molecules up to six times deeper than leading competitors, resulting in significant reductions in pain and inflammation. Their Dream Water® product line targets sleep improvement[1][3].

Therapeutic areas: ImmunologyNeurology
Modalities: Small molecule (for topical pain relief creams)Natural product (e.g., Rutin from ruta graveolens)Transdermal delivery system
Industry: Biotech

Drug pipeline

3 assets

SatiGreen

Unknown

2 more assets in the full pipeline.

Request access →

Partnerships

QVC for US distribution of Dream Water®

Beyond the preview

Go deeper on Delivra Health Brands.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Delivra Health Brands.

Explore the full profile